Literature DB >> 30287068

Role of Genetic Susceptibility in the Development of Bronchopulmonary Dysplasia.

Richard B Parad1, Abigail B Winston2, Leslie A Kalish3, Munish Gupta4, Ivana Thompson5, Yvonne Sheldon2, Joann Morey2, Linda J Van Marter6.   

Abstract

OBJECTIVE: To assess heritable contributions to bronchopulmonary dysplasia (BPD) risk in a twin cohort restricted to gestational age at birth <29 weeks. STUDY
DESIGN: A total of 250 twin pairs (192 dichorionic, 58 monochorionic) born <29 weeks gestational age with known BPD status were identified. Three statistical methods applicable to twin cohorts (χ2 test, intraclass correlations [ICCs], and ACE modeling [additive genetic or A, common environmental or C, and unique environmental or E components]) were applied. Heritability was estimated as percent variability from A. Identical methods were applied to a subcohort defined by zygosity and to an independent validation cohort.
RESULTS: χ2 analyses comparing whether neither, 1, or both of monochorionic (23, 19, 16) and dichorionic (88, 56, 48) twin pairs developed BPD revealed no difference. Although there was similarity in BPD outcome within both monochorionic and dichorionic twin pairs by ICC (monochorionic ICC = 0.34, 95% CI [0.08, 0.55]; dichorionic ICC = 0.39, 95% CI [0.25, 0.51]), monochorionic twins were not more likely than dichorionic twins to have the same outcome (P = .70). ACE modeling revealed no contribution of heritability to BPD risk (% A = 0.0%, 95% CI [0.0%, 43.1%]). Validation and zygosity based cohort results were similar.
CONCLUSIONS: Our analysis suggests that heritability is not a major contributor to BPD risk in preterm infants <29 weeks gestational age.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ACE modeling; bronchopulmonary dysplasia; disease risk; extremely low gestational age newborns; genetics; heritability; twin study

Mesh:

Year:  2018        PMID: 30287068     DOI: 10.1016/j.jpeds.2018.07.099

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

Review 1.  Bronchopulmonary dysplasia.

Authors:  Bernard Thébaud; Kara N Goss; Matthew Laughon; Jeffrey A Whitsett; Steven H Abman; Robin H Steinhorn; Judy L Aschner; Peter G Davis; Sharon A McGrath-Morrow; Roger F Soll; Alan H Jobe
Journal:  Nat Rev Dis Primers       Date:  2019-11-14       Impact factor: 52.329

2.  Differences in clinical and laboratory biomarkers for short and long-term respiratory outcomes in preterm neonates.

Authors:  Richard B Parad; Janis L Breeze; Norma Terrin; Lynette K Rogers; Carolyn M Salafia; Anne Greenough; Jonathan M Davis
Journal:  Pediatr Pulmonol       Date:  2021-08-26

Review 3.  Bronchopulmonary Dysplasia: Then, Now, and Next.

Authors:  Michael C Tracy; David N Cornfield
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2020-09       Impact factor: 0.885

Review 4.  Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Treatment of Bronchopulmonary Dysplasia.

Authors:  Yufeng Xi; Rong Ju; Yujia Wang
Journal:  Front Pediatr       Date:  2022-04-04       Impact factor: 3.569

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.